Novel Agents for the Management of Endocrine Resistant Breast Cancer
{{output}}
Purpose of review: Most women with hormone receptor (HR)-positive, HER2-negative (HR+/HER2-) breast cancer will ultimately develop endocrine-resistant disease, either primary or acquired. This review will discuss the proposed mec... ...
